PFAS, PAHs & Dioxins: 10 Key Risks for HSE Managers

For years, WHS strategies have focused on what workers breathe in.

But a growing body of evidence is highlighting a different exposure pathway — one that is often overlooked and significantly underestimated: skin absorption.

For HSE Managers across mining, emergency services, and heavy industry, this shift has serious implications.ce risk.

Introduction

In occupational health and safety (WHS), the focus has traditionally been on airborne hazards — what workers breathe in.

We mandate respirators, monitor air quality, and install ventilation systems.

However, emerging research and evolving regulations are shifting attention toward a more insidious threat:

Dermal absorption

For HSE Managers across mining, emergency services, and industrial sectors, three acronyms are becoming increasingly critical:

  • PFAS
  • PAHs
  • Dioxins

 

These contaminants are persistent, complex, and often invisible — yet they represent a significant long-term risk to worker health.

Understanding how they behave — and how to control them — is now essential.

 

1. Different Mechanisms Require Different Control Strategies

Not all persistent organic pollutants behave the same way.

  • Dioxins act primarily through a single receptor pathway
  • PFAS operate through multiple biological mechanisms

 

This means one-size-fits-all decontamination does not work

Effective control requires:

  • targeted chemistry
  • immediate removal
  • correct application method
 

2. These Contaminants Are Extremely Persistent

PFAS, PAHs, and dioxins are highly resistant to breakdown.

  • PAHs are common in diesel soot and smoke
  • Diesel Particulate Matter (DPM) is classified as a Group 1 carcinogen

 

Once on the skin, these contaminants do not simply wear off

Without intervention:

  • they remain on the dermis
  • natural oils assist absorption
  • systemic exposure increases
 
 

3. PFAS Behave Differently in the Body

Unlike dioxins:

  • PFAS bind to proteins
  • accumulate in blood, liver, and kidneys

 

This changes how exposure is monitored

  • Fat-based testing = ineffective
  • Blood serum = current benchmark
 

4. Regulatory Standards Are Tightening Rapidly

Regulators are moving fast.

  • PFAS limits now measured in nanograms per litre
  • Standards are approaching detection limits

Direction is clear:

What was “acceptable” before
is now becoming non-compliant

 

5. Serum Levels Are Now a Health Indicator

Emerging guidance shows:

  • PFAS > 20 ng/mL = increased health risk

 

For high-exposure industries:

  • firefighting
  • mining
  • aviation
  • heavy industry

 

Health monitoring is becoming essential.

 

6. Not All PFAS Are Equal

  • Long-chain PFAS = higher persistence
  • Short-chain PFAS = still risky

“PFAS-free” or “safer alternatives” ≠ zero risk

HSE Managers must:

  • understand specific compounds onsite
  • not rely on assumptions
 

7. Skin is a Major Exposure Pathway

This is the critical shift.

PAHs are:

  • lipophilic (bind to oils)
  • readily absorbed through skin

 

High-risk areas:

  • face
  • neck
  • ears
  • PPE interface zones

 

Heat + sweat:
* increases absorption rates significantly

* Standard soap and water is often not enough

 

8. PFAS Are Not Going Away

Unlike dioxins:

  • PFAS were intentionally engineered
  • still widely used

 

Elimination is slow

So:
Exposure control becomes the priority

 

9. Decontamination is a Critical Control Measure

Occupational cancer risk is strongly linked to PAHs.

Key principle:

Reduce skin contamination immediately

Practical protocol:

Step 1 – Targeted Decon

  • Face
  • Neck
  • Ears

 

Step 2 – Full Body Wipe

  • Arms
  • Torso
  • Legs

 

Step 3 – Secondary Decon

  • Tools
  • Steering wheels
  • Equipment

 

This prevents cross-contamination and take-home exposure

 
 

10. Not All “Cleaning” is Equal

“Clean” is not measurable without evidence.

HSE Managers should look for:

  • Scientific validation
  • Dermatological safety
  • Operational usability

 

Example:

  • 91% removal of Benzo[a]pyrene (PAH)
  • 94% for Dibenzo[a,h]anthracene
  • 98% for the most harmful Dioxin (TCDD)

 

Results from a DeWipe single pass, as per scientific methodology ASTM D6661-17.

Independently tested by Manchester Metropolitan University, England.

Dermatologically Tested and rated “Excellent” for skin safety.

This is the level of evidence required today.

 
 

Bridging the Gap: From Knowledge to Action

Understanding risk is only half the job.

Implementation is what matters.

For decontamination to work:

  • it must be accessible
  • it must be fast
  • it must be used consistently

 

Whether on a:

  • mine site
  • fireground
  • industrial facility

 

The goal is the same:

Reduce toxic load on skin immediately

 

Summary of Key Evidence

The table below summarises how these contaminants differ in source, risk, and decontamination priority:

 

Request a Decontamination Review

Importantly, effective decontamination requires more than traditional washing methods. Field-ready, including waterless solutions that enable immediate removal of contaminants at the point of exposure are becoming an increasingly important part of modern WHS protocols.

Is your current WHS protocol addressing dermal exposure risk?

Many standard cleaning processes:

  • fail to remove microscopic PAHs
  • allow contaminants to remain on skin

 

DeWipe Australasia provides:

  • Scientifically validated solutions
  • 100% biodegradable products
  • Practical, field-ready systems
  • Multiple format options
 

Take the next step:

✔ Request a 10-minute decontamination review
✔ Book a site trial
✔ Assess your current protocols against latest research

👉 Visit dewipe.au

 

Request a Decontamination Review

Ensure your current protocols align with modern WHS requirements and effectively manage dermal exposure risks.

✔ 10-minute expert review of your current process
✔ Practical, field-ready recommendations
✔ Identify gaps in dermal exposure control
✔ No obligation – purely advisory

Suitable for mining, emergency services, construction, and industrial environments.

Paul Bennett

————————————————–
Managing Director
DeWipe Australasia Pty Ltd
paul@dewipe.au
+61 (0)434 057 721